|
1
|
Globocan 2012: Estimated Cancer Incidence,
Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxMarch
31–2014
|
|
2
|
Fock KM: Review article: The epidemiology
and prevention of gastric cancer. Aliment Pharmacol Ther.
40:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Ervik M, et al;
International Agency for Research on Cancer. GLOBOCAN 2012 Cancer
incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.frNovember 20–2014
|
|
4
|
Howlader N, Noone AM, Krapcho M, et al;
National Cancer Institute. SEER Cancer statistics review,
1975–2011. http://seer.cancer.gov/csr/1975_2011/June
21–2014
|
|
5
|
Makeyev EV and Maniatis T: Multilevel
regulation of gene expression by microRNAs. Science. 319:1789–1790.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leung AK and Sharp PA: MicroRNA functions
in stress responses. Mol Cell. 40:205–215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan B, Zhao LH, Guo JT and Zhao JL:
miR-429 regulation of osmotic stress transcription factor 1 (OSTF1)
in tilapia during osmotic stress. Biochem Biophys Res Commun.
426:294–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
DeSano JT and Xu L: MicroRNA regulation of
cancer stem cells and therapeutic implications. AAPS J. 11:682–692.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu W, He J, Chen D, et al: Expression of
miR-29c, miR-93 and miR-429 as potential biomarkers for detection
of early stage non-small lung cancer. PLoS One. 9:e877802014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schultz NA, Dehlendorff C, Jensen BV, et
al: MicroRNA biomarkers in whole blood for detection of pancreatic
cancer. JAMA. 311:392–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmed FE, Ahmed NC, Vos PW, et al:
Diagnostic microRNA markers to screen for sporadic human colon
cancer in stool: I. Proof of principle. Cancer Genomics Proteomics.
10:93–113. 2013.
|
|
15
|
Li J, Du L, Yang Y, et al: MiR-429 is an
independent prognostic factor in colorectal cancer and exerts its
anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Li M, Zang W, et al: MiR-429
up-regulation induces apoptosis and suppresses invasion by
targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol
(Dordr). 36:385–394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krützfeldt J, Rajewsky N, Braich R, et al:
Silencing of microRNAs in vivo with ‘antagomirs’. Nature.
438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan X, He J, Sun F and Gu J: Effects and
interactions of MiR-577 and TSGA10 in regulating esophageal
squamous cell carcinoma. Int J Clin Exp Pathol. 6:2651–2667.
2013.PubMed/NCBI
|
|
19
|
Kim CH, Kim HK, Rettig RL, et al: miRNA
signature associated with outcome of gastric cancer patients
following chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei Z, Jiang S, Zhang Y, et al: The effect
of microRNAs in the regulation of human CYP3A4: A systematic study
using a mathematical model. Sci Rep. 4:42832014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suzuki T, Yasui W, Yokozaki H, Naka K,
Ishikawa T and Tahara E: Expression of the E2F family in human
gastrointestinal carcinomas. Int J Cancer. 81:535–538. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ciafre SA and Galardi S: microRNAs and
RNA-binding proteins: A complex network of interactions and
reciprocal regulations in cancer. RNA biol. 10:935–942. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lai JP, Chien JR, Moser DR, et al: hSulf1
Sulfatase promotes apoptosis of hepatocellular cancer cells by
decreasing heparin-binding growth factor signaling.
Gastroenterology. 126:231–248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nojima H: G1 and S-phase checkpoints,
chromosome instability, and cancer. Methods Mol Biol. 280:3–49.
2004.PubMed/NCBI
|
|
25
|
Humbert PO, Verona R, Trimarchi JM, Rogers
C, Dandapani S and Lees JA: E2f3 is critical for normal cellular
proliferation. Genes Dev. 14:690–703. 2000.
Bartek J and Lukas J: Mammalian G1- and
S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol.
13:738–747. 2001.PubMed/NCBI
|
|
26
|
Lee MY, Moreno CS and Saavedra HI: E2F
activators signal and maintain centrosome amplification in breast
cancer cells. Mol Cell Biol. 34:2581–2599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nevins JR: The Rb/E2F pathway and cancer.
Hum Mol Genet. 10:699–703. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiao F, Zhang W, Chen L, et al:
MicroRNA-503 inhibits the G1/S transition by downregulating cyclin
D3 and E2F3 in hepatocellular carcinoma. J Transl Med. 11:1952013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leone G, DeGregori J, Yan Z, et al: E2F3
activity is regulated during the cell cycle and is required for the
induction of S phase. Genes Dev. 12:2120–2130. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Olsson AY, Feber A, Edwards S, et al: Role
of E2F3 expression in modulating cellular proliferation rate in
human bladder and prostate cancer cells. Oncogene. 26:1028–1037.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren XS, Yin MH, Zhang X, et al:
Tumor-suppressive microRNA-449a induces growth arrest and
senescence by targeting E2F3 in human lung cancer cells. Cancer
Lett. 344:195–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hollern DP, Honeysett J, Cardiff RD and
Andrechek ER: The E2F transcription factors regulate tumor
development and metastasis in a mouse model of metastatic breast
cancer. Mol Cell Biol. 34:3229–3243. 2014. View Article : Google Scholar : PubMed/NCBI
|
